ACR Recommendations for Hydroxychloroquine Management During the COVID-19 Pandemic
The American College of Rheumatology released guiding principles for the allocation, use, and management of hydroxychloroquine during the COVID-19 pandemic.
Systemic Lupus Erythematosus
Severe Illness Reported With Nonpharmaceutical Chloroquine Misuse for COVID-19 Prevention
The product that sickened the couple was in powder form and was labeled “for Ornamental Fish Use Only.”
Voclosporin Improves Renal Outcomes in Active Lupus Nephritis
Patients with active lupus nephritis who received voclosporin experienced a superior renal response as patients receiving standard of care.
Shortages Seen for Drugs That Show Promise Against COVID-19
Strong demand for medications that show promise as treatments for COVID-19 have led to shortages of those drugs in the United States.
Increased Lupus Flare Frequency Associated With Worsened Patient Outcomes
Researchers evaluated the relationship between lupus flare frequency and patient outcomes and economic burden.
Development of Damage Strongly Associated With Increased Mortality in SLE
Researchers conducted an analysis of factors affecting damage development in patients with systemic lupus erythematosus.
Managing Dental and Orofacial Manifestations of Systemic Lupus Erythematosus
Researchers have addressed the diagnosis and management of dental and orofacial manifestations in patients with systemic lupus erythematosus, as no guidelines are currently available.
Adverse Outcomes After Percutaneous Coronary Intervention More Prevalent in SSc, SLE
Patients with systemic sclerosis and systemic lupus erythematosus were found to be at increased odds of adverse clinical outcomes and bleeding, respectively, after percutaneous coronary intervention.
A Vision for Lupus Develops Calls to Action to Improve Quality of Lupus Care
Patricia Cagnoli, MD, discusses the current gaps in lupus care and A Vision for Lupus initiative that aims to raise awareness and improve access to healthcare for patients with lupus.
Adherence to Antimalarial Therapy Reduces Risk for Type 2 Diabetes in SLE
Adherence to antimalarial therapy can provide a protective effect against the development of type 2 diabetes in patients with systemic lupus erythematosus.
Next post in Systemic Lupus Erythematosus
